- Home
- BCRX vs USA Comparison
BCRX vs USA Comparison
Compare BCRX & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- USA
- Stock Information
- Founded
- BCRX 1986
- USA 1986
- Country
- BCRX United States
- USA United States
- Employees
- BCRX N/A
- USA N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- USA Finance Companies
- Sector
- BCRX Health Care
- USA Finance
- Exchange
- BCRX Nasdaq
- USA Nasdaq
- Market Cap
- BCRX 1.7B
- USA 2.0B
- IPO Year
- BCRX 1994
- USA N/A
- Fundamental
- Price
- BCRX $7.03
- USA $7.10
- Analyst Decision
- BCRX Buy
- USA
- Analyst Count
- BCRX 6
- USA 0
- Target Price
- BCRX $14.67
- USA N/A
- AVG Volume (30 Days)
- BCRX 2.5M
- USA 880.5K
- Earning Date
- BCRX 11-04-2024
- USA 01-01-0001
- Dividend Yield
- BCRX N/A
- USA 9.66%
- EPS Growth
- BCRX N/A
- USA N/A
- EPS
- BCRX N/A
- USA N/A
- Revenue
- BCRX $412,579,000.00
- USA N/A
- Revenue This Year
- BCRX $37.24
- USA N/A
- Revenue Next Year
- BCRX $19.30
- USA N/A
- P/E Ratio
- BCRX N/A
- USA N/A
- Revenue Growth
- BCRX 29.92
- USA N/A
- 52 Week Low
- BCRX $4.03
- USA $5.62
- 52 Week High
- BCRX $8.88
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- BCRX 40.38
- USA 42.87
- Support Level
- BCRX $6.85
- USA $7.00
- Resistance Level
- BCRX $8.25
- USA $7.49
- Average True Range (ATR)
- BCRX 0.46
- USA 0.09
- MACD
- BCRX -0.08
- USA -0.00
- Stochastic Oscillator
- BCRX 11.32
- USA 20.41
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a closed-end funds and open-end multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing primarily in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication and other services.